Daniel Egle
Impact in
- Cancer Research top 2%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 2%
- Bone health and treatments
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Breast Cancer Treatment Studies 28
- Oncology 37
- HER2/EGFR in Cancer Research 19
- Cancer Treatment and Pharmacology 12
- Bone health and treatments 4
- Co-authors
- Christian Marth (14 shared papers)Heidi Fiegl (6 shared papers)Martin Widschwendter (3 shared papers)Gilbert Spizzo (1 shared paper)Daniel J. Weisenberger (1 shared paper)Elisabeth Mueller‐Holzner (1 shared paper)Peter W. Laird (1 shared paper)Ian J. Jacobs (1 shared paper)
- Journals
- Annals of Oncology (8 papers)The Breast (8 papers)ESMO Open (6 papers)Breast Cancer Research and Treatment (5 papers)European Journal of Cancer (4 papers)
- Partner nations
- AustriaUnited StatesSwitzerland
In The Last Decade
Daniel Egle
87 papers receiving 4.1k citations
Daniel Egle's Hit Papers
Peers
Comparison fields: 5 of 120
- Cancer Research 989
- Oncology 1.6k
- Pulmonary and Respiratory Medicine 762
- Orthopedics and Sports Medicine 173
- Molecular Biology 1.4k
Countries citing papers authored by Daniel Egle
This map shows the geographic impact of Daniel Egle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Egle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Egle more than expected).
Fields of papers citing papers by Daniel Egle
This network shows the impact of papers produced by Daniel Egle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Egle. The network helps show where Daniel Egle may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Egle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 94 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Epigenetic stem cell signature in cancer Hit paper breakdown → | 2006 | 879 |
| 2 | Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial Hit paper breakdown → | 2015 | 426 |
| 3 | 2017 | 336 | |
| 4 | Pathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple-negative, early high-risk and locally advanced breast cancer: NeoTRIP Michelangelo randomized study Hit paper breakdown → | 2022 | 267 |
| 5 | Spatial predictors of immunotherapy response in triple-negative breast cancer Hit paper breakdown → | 2023 | 240 |
| 6 | Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study Hit paper breakdown → | 2021 | 196 |
| 7 | 2019 | 192 | |
| 8 | 2021 | 111 | |
| 9 | 2021 | 107 | |
| 10 | 2019 | 84 | |
| 11 | 2010 | 81 | |
| 12 | Neoadjuvant nivolumab and chemotherapy in early estrogen receptor-positive breast cancer: a randomized phase 3 trial Hit paper breakdown → | 2025 | 74 |
| 13 | 2012 | 73 | |
| 14 | 2016 | 70 | |
| 15 | 2011 | 65 | |
| 16 | 2011 | 63 | |
| 17 | 2011 | 59 | |
| 18 | 2021 | 44 | |
| 19 | 2017 | 44 | |
| 20 | 2020 | 42 |
About Daniel Egle
Daniel Egle is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Dermatology, having authored 94 papers that have together received 4.2k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (28 papers), HER2/EGFR in Cancer Research (19 papers), Advanced Breast Cancer Therapies (18 papers), Cancer Treatment and Pharmacology (12 papers), Breast Implant and Reconstruction (6 papers), Reconstructive Surgery and Microvascular Techniques (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Bone health and treatments (4 papers). The work is most often cited by research in Cancer Research (989 citations), Oncology (1.6k citations), Pulmonary and Respiratory Medicine (762 citations), Orthopedics and Sports Medicine (173 citations) and Molecular Biology (1.4k citations). Daniel Egle has collaborated with scholars based in Austria, United States and Switzerland. Frequent co-authors include Christian Marth, Heidi Fiegl, Martin Widschwendter, Gilbert Spizzo, Daniel J. Weisenberger, Elisabeth Mueller‐Holzner, Peter W. Laird, Ian J. Jacobs, Joanne P Young and Mihaela Campan. Their work appears in journals such as Annals of Oncology, The Breast, ESMO Open, Breast Cancer Research and Treatment and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.